PRLD
Prelude Therapeutics Inc

1,136
Mkt Cap
$126.44M
Volume
295,352.00
52W High
$4.22
52W Low
$0.6101
PE Ratio
-1.04
PRLD Fundamentals
Price
$1.60
Prev Close
$1.67
Open
$1.65
50D MA
$1.43
Beta
1.82
Avg. Volume
247,204.78
EPS (Annual)
-$1.68
P/B
1.61
Rev/Employee
$53,435.11
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...
PR Newswire·8h ago
News Placeholder
More News
News Placeholder
Prelude Therapeutics (NASDAQ:PRLD) Issues Earnings Results
Prelude Therapeutics (NASDAQ:PRLD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.26) earnings per share for the quarter, topping the consensus...
MarketBeat·7d ago
News Placeholder
Prelude Therapeutics Inc Q3 Loss Decreases, Beats Estimates
(RTTNews) - Prelude Therapeutics Inc (PRLD) revealed Loss for third quarter that decreased from the same period last year and beat the Street estimates...
Nasdaq News: Markets·8d ago
News Placeholder
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prelude Therapeutics Incorporated (Prelude or the Company...
Business Wire·9d ago
News Placeholder
Prelude Therapeutics (PRLD, $4.62) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024
This indicator may be signaling that PRLD's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Prelude Therapeutics (PRLD, $4.61) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 26, 2024
This is a Bearish indicator signaling PRLD's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Stocks·2y ago
News Placeholder
Prelude Therapeutics initiated with bullish view at JMP Securities, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Prelude Therapeutics (PRLD, $4.1) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 12, 2024
This is a Bearish indicator signaling PRLD's price could decline from here. Traders may explore shorting the stock or put options...
Tickeron - Stocks·2y ago
News Placeholder
Prelude Therapeutics (PRLD, $4.1) entered Downtrend as Momentum indicator drops below 0 level on Mar 12, 2024
This indicator may be signaling that PRLD's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·2y ago
News Placeholder
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
Posters to highlight highly selective oral SMARCA2 degrader, potentially best-in-class CDK9 inhibitor and next-generation CDK4/6 inhibitorWILMINGTON, Del., March 05, 2024 (GLOBE NEWSWIRE...
Globe Newswire·2y ago

Latest PRLD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.